Cladribine Back in the Running for Multiple Sclerosis Cladribine Back in the Running for Multiple Sclerosis
In an analysis of both the CLARITY and CLARITY Extension studies, cladribine tablets showed strong efficacy and a good safety profile. No cancers were observed.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
More News: Brain | Cancer | Cancer & Oncology | Health | Multiple Sclerosis | Neurology | Neurosurgery | Study